Back to company

Organon Denmark ApS: Financial statements 2020

CVR: 41193093

Organon Denmark ApS (CVR 41193093) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 49,240,000 and a net result of DKK 1,338,000. The profit margin was 2.7%. Equity amounted to DKK 22,666,000. The solvency ratio was 36%. The company had 5 employees in the financial year.

Revenue
49,240,000 kr.
Gross Profit
4,382,000 kr.
Profit/Loss
1,338,000 kr.
Equity
22,666,000 kr.
Total Assets
62,896,000 kr.
Employees
5

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Organon Denmark ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Registered as owner of Organon Denmark ApSNov 3, 2020

As of November 3, 2020, is registered as an owner of Organon Denmark ApS with an ownership share of 100%.

Organon Denmark ApS appoints new auditorFeb 24, 2020

As of February 24, 2020, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Organon Denmark ApS.

Andreas Daugaard Jørgensen joins Organon Denmark ApS as directorFeb 24, 2020

As of February 24, 2020, Andreas Daugaard Jørgensen is registered as director of Organon Denmark ApS.

Torstein Ljøkjel Erskov Winterstø joins Organon Denmark ApS as directorFeb 24, 2020

As of February 24, 2020, Torstein Ljøkjel Erskov Winterstø is registered as director of Organon Denmark ApS.

Funda Zeynep Ekincioglu joins Organon Denmark ApS as directorFeb 24, 2020

As of February 24, 2020, Funda Zeynep Ekincioglu is registered as director of Organon Denmark ApS.

Organon Denmark ApS is foundedFeb 24, 2020

Organon Denmark ApS was founded on February 24, 2020.

About Organon Denmark ApS

Organon Denmark ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karl Johan Sundt, Sofia Raquel Paulos Ferreira Alves da Silva and Anne Bitzer. The company is owned by OBS Human Health Holding B.V.. In 2025, the company reported revenue of DKK 61,554,000 and a net result of DKK 3,139,000 compared with DKK 2,428,000 the year before. Equity amounted to DKK 31,049,000.

Other financial years